In endometriosis, IL-33/ST2 inhibits ATF3 by activating the p38/JNK signaling pathway, thereby upregulating the expression of SLC7A11, reducing ferroptosis, and protecting endometriotic stromal cells (eESCs) from damage (49). Here, ATF3 is linked to endometriosis.